Blood Sample Protein Measurement Analysis
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Washington DC VA Medical Center, is conducting market research through a Sources Sought notice for Blood Sample Protein Measurement Analysis. This effort aims to identify qualified contractors capable of generating high-quality proteomic data from plasma specimens of Veterans with advanced prostate cancer to inform biomarker validation and precision oncology strategies. Responses are due by May 15, 2026.
Purpose
The VA is conducting a prospective biospecimen collection and clinical data repository study focused on advanced prostate cancer. The goal is to generate reproducible, high-quality proteomic data from longitudinal plasma specimens to link circulating proteomic changes to clinical outcomes, supporting future biomarker validation studies and precision oncology for Veterans.
Scope of Work
Potential services, as outlined in the Statement of Work, include:
- Receiving coded frozen plasma aliquots from the VA.
- Thawing and preparing plasma samples for SomaScan assay processing.
- Performing SomaScan assay processing, including standard assay-level quality control.
- Returning proteomic data output in standard ADAT file format, accompanying quality assurance documentation, and any unused sample material.
- Processing samples in study batches, with the current scope anticipating approximately 120 total plasma samples from about 24 participants.
Requirements & Contract Details
- Anticipated Contract Type: Firm Fixed Price Contract.
- Period of Performance: Base year with a one-year option period.
- Place of Performance: Vendor's facility.
- Special Requirements: The vendor must possess an established, analytically validated, CLIA-certified plasma proteomic assay platform. All work must adhere to the vendor's standard operating procedures and VA requirements, with strict confidentiality and data protection.
- Product Service Code: AN11 (Health R&D Services; Health Care Services; Basic Research).
- Set-Aside: None specified.
Information Requested
This is a Sources Sought notice for market research only, not a Request for Quotation. Interested and capable respondents should provide:
- Business information (name, address, type, socio-economic status, contact person).
- Unique Entity Identifier (UEI) number.
- Small business status under NAICS code 541715 (Research and Development in the Physical, Engineering, and Life Sciences).
- A capability statement and summary of experience demonstrating ability to provide the required services.
- Information on GSA Federal Supply Schedule contracts.
Timeline & Submission
- Response Due: May 15, 2026, by 3:00 PM (EDT).
- Submission: Via email to Veronica B. Dillard (veronica.dillard@va.gov).
- Published Date: May 1, 2026.
Additional Notes
The government will not pay for any information or administrative costs incurred in response to this notice. Not responding does not preclude future participation in a potential Request for Quotation.